The eyes are a window to the brain – and this outward extension of the central nervous system may reveal early signs of ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

Stop doomscrolling! Test your visual perception and attention to detail by spotting the hidden word FARE among FAIR in 7 seconds in this optical illusion. Test your observation skills now!

This quick visual challenge will reveal whether you truly have the detail-oriented mind most people only wish they had.

Optical illusions test your visual acuity and depth perception skills. Only 1% with eagle eyes can find the word 'SEA' in the word grid in 5 seconds. Do you have that rare skill? Find out now!

Dive into this brain-teasing optical illusion where numbers play tricks on your eyes. Can you spot the odd one out in the sea ...

While expressing disappointment, William Blair analysts were unsurprised by the Phase II failure, having assigned the VISTA study a high level of risk given the “mixed” performance of a similar drug ...

Also, at the outpatient department records of the National Radiotherapy Oncology and Nuclear Medicine Centre (NRONMC), KBTH, the total number of new head and neck cancer cases in 2024 was 292, 11.1% ...

Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

During certain times of the day, some people with dementia may become more confused and disoriented. Referred to by ...

Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment ...